Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and ...
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...
Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...
Eli Lilly (NYSE:LLY) reported positive results from an open-label study of its drug Omvoh in the treatment of moderately to severely active Crohn's disease. The study, called VIVID-2, showed that the ...
Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz). In January, the FDA approved Omvoh for moderately to severely active Crohn's ...
INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...
Omvoh has additional ongoing trials in Crohn's disease and UC, including studies to evaluate the long-term efficacy and safety of Omvoh in pediatric patients and adults, and a Phase 4 real-world ...
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
One study compared the hospitalization burdens of individuals with diverticulitis and either Crohn’s disease or ulcerative colitis, another form of IBD. It found that the burdens were actually ...
For FY2025, the company anticipates revenue to be in the range of $58 to $61 billion, driven by products such as Jaypirca, Ebglyss, Omvoh, and Kisunla, along with the market expansion of Mounjaro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results